Abstract
It is abundantly clear that interactions occur between the immune, endocrine, central, and autonomic nervous systems. Immunologic manipulations (or products of an activated immune system, e.g., cytokines) affect neuroendocrine and central neurotransmitter processes, and conversely, neuroendocrine and central neurotransmitter alterations may impact on immune activity (Anisman, Zalcman, & Zacharko, 1993; Blalock, 1994; Dunn, 1990; Rivier, 1993; Rothwell & Hopkins, 1995). It has been posited that, among other things, the immune system acts like a sensory organ informing the brain of antigenic challenge (Blalock, 1984, 1994). Furthermore, given the nature of the neurochemical changes elicited by antigens and cytokines, it was suggested that immune activation may be interpreted by the CNS as a stressor (Anisman et al., 1993; Dunn, 1990; Dunn, Powell, Meitin, & Small, 1989). To be sure, the effects of systemic Stressors (e.g., those associated with viral insults, bacterial endotoxins, cytokines) are not entirely congruous with those elicited by processive stressors (i.e., those involving higher-order sensory processing, e.g., fear conditioning, exposure to a predator or novel environment) (Herman & Cullinan, 1997). Nevertheless, cytokines may be part of a regulatory loop that, by virtue of effects on CNS functioning, might influence behavioral outputs and may even contribute to the symptoms of behavioral pathologies, including mood and anxiety-related disorders (Anisman et al., 1993; Crnic, 1991). It is curious that while cytokines have found an increasingly greater role in immunotherapy, and may contribute to neurodegenerative processes (Rothwell, Luheshi, & Toulmond, 1996), limited attention has been devoted to behavioral analyses of these cytokines in animal studies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alonso, R., Chaudieu, I., Dori, J., Krishnamurthy, A., Quirion, R., & Boksa, P. (1993). Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells, Journal of Neurochemistry, 61, 1284–1290.
Anisman, H., Zalcman, S., Shanks, N., & Zacharko, R. M. (1991). Multisystem regulation of performance deficits induced by Stressors: An animal model of depression. In A. Boulton, G. Baker, & M. Martin-Iverson (Eds.), Neuromethods, vol. 19: Animal Models of Psychiatry, II. (pp. 1–59). New Jersey: Humana Press.
Anisman, H., Zalcman, S., & Zacharko, R. M. (1993). The impact of Stressors on immune and central neurotransmitter activity: Bidirectional communication. Reviews in the Neurosciences, 4, 147–180.
Anisman, H., Kokkinidis, L., & Merali, Z. (1996). Influence of interleukin-2 on responding for electrical brain stimulation from the hypothalamus. Brain Research, 731, 1–11.
Anisman, H., Lu, Z. W., Song, C, Kent, P., Mclntyre, D. C, & Merali, Z. (1997). Influence of psychogenic and neurogenic Stressors on endocrine and immune activity: differential effects in fast and slow seizing rat strains. Brain, Behavior, and Immunity, 11, 63–74.
Anisman, H., Kokkinidis, L., Borowski, T., & Merali, Z. (1998a). Differential effects of interleukin (IL)-l, IL-2, and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research, 779, 177–187.
Anisman, H., Ravindran, A. V., Griffiths, J., & Merali, Z. (1998b). Behavioral, endocrine, and cytokine correlates of major depression and dysthymia with typical or atypical features. Molecular Psychiatry, in press
Araujo, B. M., Lapchak, P. A., Collier, B., & Quirion, R. (1989). Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Research, 498, 257–266.
Ban, E. M., Haour, F., & Lenstra, R. (1992). Brain interleukin-1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine, 4, 48–54.
Banks, W. A., Ortz, L., Plotkin, S. R., & Kasten, A. J. (1991). Human interleukin (IL)-l alpha, murine IL-1 alpha, and murine IL-2 beta are transported from blood to brain in the mouse by a shared saturable mechanism. Journal of Pharmacological and Experimental Therapeutics, 259, 988–996.
Bartanusz, V, Jezova, D., Bertini, L. T., Tilders, F. J., Aubry, J. M., & Kiss, J. Z. (1993). Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology, 132, 895–902.
Bartholemew, S. A. & Hoffman, S. A. (1993). Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain, Behavior, and Immunity, 7, 301–316.
Blalock, J. E. (1984). The immune system as a sensory organ. Journal of Immunology, 132, 1067–1070.
Blalock, J. E. (1994). The syntax of immune-neuroendocrine communication. Immunology Today, 15, 504–511.
Bluthe, R. M., Dantzer, R., & Kelley, K. W. (1989). Corticotropin releasing hormone is not involved in the behavioral effects of peripherally injected interleukin-1 in the rat. Neuroscience Research Communincations, 5, 149–154.
Bluthe, R. M., Michaud, B., Kelley, K. W., & Dantzer, R. (1996). Vagotomy attenuates behavioral effects of interleukin-1 injected peripherally but not centrally. Neuroreport, 7, 1485–1488.
Bluthe, R. M., Dantzer, R., & Kelley, K. W. (1997). Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology, 22, 1–11.
Borowski, T, Kokkinidis, L., Merali, Z., & Anisman, H. (1997). Behavioral and central monoamine alterations induced by interleukin-1, interleukin-6, and lipopolysaccharide. Society for Neurosciences Abstract, 23, 1508.
Brady, L. S., Lynn, A. B., Herkenham, M., & Gottesfeld, Z. (1994). Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. Journal of Neuroscience, 14, 4951–4964.
Brebner, K., Hayley, S., Lacosta, S., Zacharko, R., Merali, Z., & Anisman, H. (1998). Synergistic actions of interleukin (IL)-lβ, IL-6, and TNFα: Central neurochemical, neuroendocrine and behavioral alterations. Society for Neurosciences Abstract, in press.
Bret-Dibat, J. L., Bluthe, R. M., Kent, S., Kelley, K. W., & Dantzer, R. (1995). Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain, Behavior, and Immunity, 9, 242–246.
Buttini, M. & Boddeke, H. (1995). Peripheral lipopolysaccharide stimulation induces interleukin-Iβ messenger RNA in rat brain microglial cells. Neuroscience, 65, 523–530.
Capuron, L., Ravaud, A., Radat, F., Dantzer, R., & Goodall, G. (1998). Effects of interleukin-2 and alpha interferon cytokine immunotherapy on the mood and cognitive performance of cancer patients. Neuroimmunomodulation, 5, 9.
Caraceni, A., Martini, G, Belli, F., Mascheroni, L., Rivoltini, L., Arienti, F., & Cascinelli, N. (1992). Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration, European Journal of Cancer, 29A, 1266–1269.
Connor, T. J. & Leonard, B. E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sciences, 62, 583–606.
Connor, T., Song, G, Leonard, B. E., Merali, Z., & Anisman, H. (1998). An assessment of the effects of central interleukin-1 β,-2,-6 and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine, and immune parameters in the rat. Neuroscience, 84, 923–933.
Crnic, L. S. (1991). Behavioral consequences of viral infection. In R. Ader, D. L. Feiten, & N. Cohen (Eds.), Psychoneuroimmunology (pp. 749–770). San Diego: Academic Press.
Dantzer, R., Bluthe, R. M., Aubert, A., Goodall, G, Bret-Dibat, J-L., Kent, S., Goujon, E., Laye, S., Parnet, P., & Kelley, K. W. (1996). Cytokine actions on behavior. In N. J. Rothwell (Ed.), Cytokines and the Nervous System, (pp. 117–144). London: Landes.
Day, H. E. & Akil, H. (1996). Differential pattern of c-fos mRNA in the rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology, 63, 207–218.
Denicoff, K. D., Rubinow, D. R., Papa, M. Z., Simpson, L., Seipp, L. A., Lotze, M. T., Chang, A. E., Rosenstein, D., & Rosenberg, S. A. (1987). The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine, 107, 293–300.
De Sarro, G., Gareri, P., Sinopoli, V. A., David, E., & Rotiroti, D. (1997). Comparative, behavioural, and electrocortical effects of tunor necrosis factor-alpha and interleukin-1 microinjected into the locus coeruleus of rat. Life Sciences, 60, 555–564.
De Simoni, M. G, Del Bo, R., De Luigi, A., Simard, S., & Forloni, G. (1995). Central endotoxin induces different patterns of interleukin (IL)-lb and IL-6 messenger robonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology, 136, 897–902.
Dunn, A., J. (1990). Interleukin-1 as a stimulator of hormone secretion. Progress in NeuroEndocrinlmmunology, 3, 26–34.
Dunn, A. J. (1995). Interactions between the nervous system and the immune system. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 719–731). New York: Raven Press.
Dunn, A. J. & Welch, J. (1991). Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. Journal of Neurochemistry, 57, 1615–1622.
Dunn, A. J., Powell, M. L., Meitin, C, & Small, P. A. (1989). Virus infection as a stressor: Influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan. Physiology and Behavior, 45, 591–594.
Elmquist, J. K., Scammell, T. E., & Saper, C. B. (1997). Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends in Neurosciences, 20, 565–570.
Ericsson, A., Kovacs, K. J., & Sawchenko, P. E. (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. Journal of Neuroscience, 14, 89–913.
Ericcson, A., Ek, M., Wahlstrom, I., Kovacs, K., Liu, C-L., Hart, R., & Sawchenko, P. E. (1996). Pathways and mechanisms for interleukin-1 mediated regulation of the hypothalamo-pituitary-adrenal axis. In R. McCarty, G. Aguilera, E. L. Sabban, & R. Kvetnancky (Eds.), Stress: molecular genetic and neurobiological advances (pp. 101–120). New York: Gordon & Breach.
Ericsson, A., Arias, C, & Sawchenko, P. E. (1997). Evidence for an intermedullary prostaglandin-dependent mechanism in the activation of stres-related neuroendocrine circuitry by intravenous interleukin-1. Journal of Neuroscience, 17, 7166–7179.
Fibiger, H. C. & Phillips, A. G. (1988). Mesocorticolimbic dopamine systems and reward. In P. Kalivas & C. Nemeroff (Eds.), The Mesocorticolimbic System, (pp. 206–215). New York: New York Academy of Science.
Gabellec, M-M., Griffais, R., Fillion, G, & Haour, F. (1996). Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. Journal of Neuroimmunology, 66, 65–70.
Gaillard, R. C. (1995). Immunoendocrine interactions at the hypothalamo-pituitary level. Annales D’Endocrinologie, 56, 561–566.
Gold, P. W., Chrousos, G. P., Kellner, C, Post, R. M., Roy, A., Augerinas, P., Schulte, H., Oldgield, E. H., & Loriaux, D. L. (1984). Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. American Joural of Psychiatry 141 619–627
Gray, T. S. (1991). Amygdala: Role in autonomic, and neuroendocrine responses to stress. In J. A. McCubbin, P. G. Kaufmann, & C. B. Nemeroff (Eds.), Stress, Neuropeptides, and Systemic Disease (pp. 37–53). New York: Academic Press.
Griffiths, J., Ravindran, A. V., Merali, Z., & Anisman, H. (1996). Immune and behavioral correlates of typical and atypical depression. Society for Neuroscieces Abstract, 22, 1350.
Gutierrez, E. G., Banks, W. A., & Kastin, A. J. (1993). Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. Journal of Neuroimmunology, 47, 169–176.
Hanisch, U-W. & Quirion, R. (1996). Interleukin-2 as a neuroregulatory cytokine. Brain Research Reviews, 21, 246–284.
Hanisch, U-W, Seto, D., & Quirion, R. (1993). Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. Journal of Neuroscience, 13, 3368–3374.
Hanisch, U-W, Rowe, W., Sharma, S., Meaney, M. J., & Quirion, R. (1994). Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology, 135, 2465–2472.
Hanisch, U-W, Neuhaus, J., Rowe, W, van Rossum, D., Moller, T., Kettenmann, H., & Quirion, R. (1997). Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience, 79, 799–818.
Haour, F., Marquette, G, Ban, E., Crumeyrolle-Arias, M., Rostene, W., Tsiang, H. & Fillion, G. (1995). Receptors for interleukin-1 in the central nervous system and neuroendocrine systems. Annales d’Endocrinologie, 56, 173–179.
Harbuz, M. S. & Lightman, S. L. (1992). Stress and the HPA axis: Acute, chronic and immunological activation. Journal of Endocrinology, 134, 327–339.
Hayley, S. Brebner, K., Staines, W, Merali, Z., & Anisman, H. (1998). Sensitization effects of tumor necrosis factor-a: behavioral, neuroendocrine and neurochemical alterations. Society for Neurosciences Abstract, in press.
Hebb, A. L. O., Zacharko, R. M., & Anisman, H. (1998). Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration. Brain Research Bulletin, 45, 549–556.
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994). Corticotropin releasing factor and neuropeptide Y: role in emotional integration. Trends in Neurosciences, 17, 80–84.
Hellerstein, M. K., Meydani, S. R, Meydani, M., Wu, K., & Dinarello, G A. (1989). Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. Journal of Clinical Investigation, 84, 228–235.
Herman, J. P. & Cullinan, W. E. (1997). Neurocircuitry of stress: Central control of hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences, 20, 78–84.
Holden, R. J. & Pakula, I. S. (1996). The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Medical Hypotheses, 47, 423–438.
Holsboer, F. (1995). Neuroendocrinology of Mood Disorders. In F. E. Bloom & Kupfer, D. J. (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 957–969). New York: Raven Press.
Hopkins, S. J., Rothwell, N. J. (1995). Cytokines and the nervous system. Trends in Neurosciences, 18, 83–88.
Ilyin, S. E. & Plata-Salaman, C. R. (1996). In vivo regulation of the IL-1 beta system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-alpha mRNAs in specific brain regions. Biochemical and Biophysical Research Communications, 227, 861–867.
Imura, H., Fukata, J-I., & Mori, T. (1991). Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clinical Endocrinology, 35, 107–115.
Kalivas, P. W. & Duffy, P. (1995). Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Research, 675, 325–328.
Katsumata, S. & Satoh, M. (1993). In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Molecular Brain Research, 20, 153–161.
Kent, S., Bluthe, R-M., Kelley, K. W, & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13, 24–28.
Kent, S., Rodriguez, F., Kelley, K. W., & Dantzer, R. (1994). Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiology and Behavior, 56, 1031–1036.
Kent, S., Bret-Dibat, J. L., Kelley, K. W, & Dantzer, R. (1996). Mechanisms of sickness-induced decreases in food-motivated behavior. Neuroscience and Biobehavioral Reviews, 20, 171–175.
Kinouchi, K., Brown, G., Pasternak, G., & Donner, D. B. (1991). Identification and characterization of receptors for tumor necrosis factor-a in the brain. Biochemical and Biophysical Research Communications, 181, 1532–1538.
Kluger, M. J. (1991). Fever: Role of endogenous pyrogens and cryogens. Physiologal Reviews, 71, 93–127.
Kokkinidis, L. & Anisman, H. (1980). Amphetamine models of paranoid schizophrenia: An overview and elaboration of animal environmentation Psychological Bulletin 88 551–579
Lacosta, S., Kulczycki, J., Merali, Z., Anisman, H. (1996). Behavioral, endocrine and central neurochemical alterations induced by interleukin-1. Society for Neurosciences Abstract, 22, 2059.
Lacosta, S., Merali, Z., & Anisman, H. (1998a). Behavioral and neurochemical consequences of acute and chronic interleukin-2 administration. Society for Neurosciences Abstract, in press, (a)
Lacosta, S., Merali, Z., & Anisman, H. (1998b). Influence of interleukin-1 on exploratory behaviors, plasma ACTH and cortisol, and central biogenic amines in mice. Psychopharmacology, in press, (b)
Lapchak, P. A. (1992). A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport, 3, 165–168.
Laye, S., Bluthe, R. M., Kent, S., Combe, C, Medina, C, Parnet, P., Kelly, K., & Dantzer, R. (1995). Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. American Journal of Physiology, 37, R1327–R1331.
Lee, Y. & Davis, M. (1997). Role of the hippocampus, bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. Journal of Neuroscience, 17, 6434–7446.
Linthorst, A. C. E., Flachskamm, C, Muller-Preuss, P. Holsboer, F., & Reul, J. M. H. M. (1995). Effect of bacterial endotoxin and interleukin-1 b on hippocampal serotonergic neurotransmision, behavioral activity, and free corticosterone levels: An in vivo microdialysis study. Journal of Neuroscience, 15, 2920–2934.
Liu, L., Kita, T., Tanaka, N., & Kinoshita, Y. (1996). The expression of tumor necrosis factor in the hypothalamus after treatment with lipopolysaccharide. International Journal of Experimental Pathology, 77, 37–44.
Loddick, S. A., MacKenzie, A., & Rothwell, N. J. (1996). An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain daage in the rat. Neuroreport, 7, 1465–1468.
Loddick, S. A., Wong, M. L., Bongiorno, P. B., Gold, P. W., Licinio, J., & Rothwell, N. J. (1997). Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochemical and Biophysical Research Communications, 234, 211–215.
Maes, M. (1995). Evidence for an immune response in major depression: A review and hypothesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 19, 11–38.
Maes, M., Bosmans, E., Suy, E., Vandervorst, C, DeJonckheere, C, Minner, B., & Raus, J. (1991). Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1β, and soluble interleukin-2-receptor production. Acta Psychiatrica Scandinavica, 84, 379–386.
Maes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, C, DeJonckheer, C, Minner, B., & Raus, J. (1992). Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychological Medicine, 22, 45–53.
Maes, M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., Peeters, D., Schotte, G, & Cosyns, P. (1993). Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 241–255.
Maes, M., Meltzer, H. Y, Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. Journal of Affective Disorders, 34, 301–309.
Maier, S. F. & Watkins, L. R. (1995). Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Research, 695, 279–286.
Maier, S. F. & Watkins, L. R. (1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review, 105, 83–107.
Masana, M. I., Heyes, M. P., & Mefford, I. N. (1990). Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 74, 609–621.
Mclntyre, D. C. (1980). Amygdala kindling in rats: facilitation after local amygdala norepinephrine depletion with 6-hydroxydopamine. Experimental Neurology, 69, 395–407.
Mefford, I. N. & Heyes, M. P. (1990). Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin. Journal of Neuroimmunology, 27, 55–61.
Mefford, I. N., Masters, C. F., Heyes, M. P., & Eskay, R. L. (1991). Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice. Brain Research, 557, 327–330.
Merali, Z., Lacosta, S., & Anisman, H. (1997). Effects of interleukin-lβ and mild stress on alterations of central monoamines: A regional microdialysis study. Brain Research, 761, 225–235.
Meyers, C. A. & Valentine, A. D. (1995). Neurological and psychiatric adverse effects of immunological therapy, CNS Drugs, 3, 56–68.
Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y., & Satoh, M. (1990). Convulsants induce inter-leukin-lb messenger RNA in rat brain. Biochemical and Biophysical Research Communications, 171, 832–837.
Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y, & Satoh, M. (1991). Immobilization stress induces interleukin-lβ mRNA in rat hypothalamus. Neuroscience Letters, 123, 254–256.
Mohankumar, P. S. & Quadri, S. K. (1993). Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sciences, 52, 1961–1967.
Mohankumar, P. S., Thyagarajan, S., & Quadri, S. K. (1991). Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo. Life Sciences, 48, 925–930.
Mohankumar, P. S., Thyagarajan, S., & Quadri, S. K. (1993). Interleukin-lβ increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Research Bulletin, 31, 745–748.
Mohapel, P. & Mclntyre, D. C. (1998). Amygdala kindling-resistant (SLOW) or-prone (FAST) rat strains show differential fear responses. Behavioral Neurosciences, in press.
Moldofsky, H. (1995). Sleep and the immune system. International Journal of Immunopharmacology, 17, 649–665.
Muaramami, N., Fukata, J., Tsukada, T., Kobayashi, H., Ebisui O. Segawa, H., Muro, S., Imura, H., & Nakao, K. (1993). Bacterial lipopolysaccharide expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology, 133, 2574–2578.
Mullar, N. & Ackenheil, M. (1998). Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 22, 1–33.
Nassberger, L. & Traskman-Bendz, L. (1993). Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatrica Scandinavica, 88, 48–52.
Nemeroff, C. B. (1996). The coricotropin-releasing factor (CRF) hypothsesis of depression: New findings and new directions. Molecular Psychiatry, 1, 336–342.
Nguyen, K. T., Deak, T, Owens, S. M., Kohno, T, Fleshner, M., Watkins, L. R., & Maier, S. F. (1998). Exposure to acute stress induces brain interleukin-lβ protein in the rat. Journal Neuroscience, 18, 2239–2246.
Petitto, J. M., McCarthy, D. B., Rinker, C. M., Huang, Z., & Getty, T. (1997). Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. Journal of Neuroimmunology, 73, 183–190.
Pitossi, F., del Rey, A., Kabiersch, A., & Besedovsky, H. (1997). Induction of cytokine transcripts in the CNS and pituitary following peripheral administration of endotoxin to mice. Journal of Neuroscience Research, 48, 287–298.
Plata-Salaman, C. R. (1989). Immunomodulators and feeding regulation: A humoral link between the immune and nervous systems. Brain, Behavior and Immunity, 3, 193–213.
Plata-Salaman, C. R. (1994). Meal patterns in response to the intracerebroventricular administration of interleukin-1<b> in rats. Physiology and Behavior, 55, 727–733.
Plata-Salaman, C. R. (1998). Cytokines and anorexia: A brief overview. Seminars in Oncology, 25, 64–72.
Quan, N., Sundar, S. K., & Weiss, J. M. (1994). Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. Journal of Neuroimmunology, 49, 125–134.
Raber, J., Koob, G. F., & Bloom, F. E. (1995). Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling: Comparison with the hypothalamic response. Journal of Pharmacology and Experimental Therapeutics, 272, 815–824.
Rajora, N., Boccoli, G., Burns, D., Sharma, S., Catania, A. P., & Lipton, J. M. (1997). α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. Journal of Neuroscience, 15, 2181–2186.
Richardson, N. R. & Roberts, D. C. S. (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluyate reinforcing efficacy. Journal of Neuroscience Methods, 66, 1–11.
Rivest, S. (1995). Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. International Journal of Developmental Neuroscience, 13, 135–146.
Rivest, S. & Rivier, C. (1994). Stress and interleukin-1 beta-induced activation of c-Fos, Ngfi-B, and CRF gene expression in the hypothalamic PVN—Comparison between Sprague-Dawley, Fisher-344, and Lewis rats. Journal of Neuroendocrinology, 6, 101–117.
Rivest, S. & Laflamme, N. (1995). Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. Journal of Neuroendocrinology, 7, 501–525.
Rivier, C. (1993). Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Annals of the New York Academy of Sciences, 697, 97–105.
Rothwell, N. J. & Hopkins, S. J. (1995). Cytokines and the nervous system II: Actions and mechanisms of action. Trends in Neurosciences, 18, 130–136.
Rothwell, N. J., Luheshi, G., & Toulmond, S. (1996). Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacology and Therapeutics, 69, 85–95.
Rothwell, N. J., Loddick, S. A., & Stroemer, P. (1997). Interleukins and cerbral ischemia. International Review of Neurobiology, 40, 291–298.
Sato, S., Reiner, S. L., Jensen, M. A., & Roos, R. P. (1997). Central nervous system mRNA expression following Theiler’s murine encephalomyelitis virus infection. Journal of Neuroimmunology, 76, 213–223.
Sawchenko, P. E., Brown, E. R., Chan, R. K. W., Ericsson, A., Li, H.-Y, Roland, B. L., & Kovacs, K. J. (1996). The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Progress in Brain Research, 107, 201–222.
Schmidt, E. D., Janszen, A. W. J. W., Wouterlood, F. G., & Tilders, F. J. H. (1995). Interleukin-1 induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH) neurons and hyperrespon-siveness of the hypothalamic-pituitary-adrenal axis. Journal of Neuroscience, 15, 7417–7426.
Schobitz, B., De Kloet, E. R., Sutanto, W., & Holsboer, F. (1993). Cellular localization of interleukin-6 mRNA and interleukin 6 mRNA in rat brain. European Journal of Neuroscience, 5, 1426–1435.
Seto, D., Karr, S., & Quirion, R. (1997). Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. British Journal of Pharmacology, 120, 1151–1157.
Shintani, F., Kanba, S., Nakaki, T., Nibuya, M., Kinoshita, N., Suzuki, E., Yagi, G., Kato, R., & Asai M. (1993). Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus, Journal of Neuroscience, 13, 3574–3581.
Shintani, F., Nakaki, T., Kanba, S., Sato, K., Kato, R., & Asai, M. (1995a). Role of interleukin-1 in stress responses. Molecular Neurobiology, 10, 41–71. a
Shintani, F., Nakaki, T., Kanba, S., Sato, K., Yagi, G., Shiozawa, M., Aiso, S., Kato, R., & Asai, M. (1995b). Involvement of interleukin-1 in immibilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. Journal of Neuroscience, 15, 1961–1970. b
Sluzewska, A., Rybakowski, J. K., Laciak, M., Mackiewicz, A., Sobieska, M., & Wiktorowicz, K. (1995). Inter-leukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences, 762, 474–476.
Smagin, G. N., Swiergiel, A. H., & Dunn, A. J. (1996). Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: Comparison with plasma corticosterone. Psychoneuroendocrinology, 21, 83–93.
Smith, R. S. (1991). The macrophage theory of depression. Medical Hypotheses, 35, 298–306.
Song, C, Dinan, T., & Leonard, B. E. (1994). Changes in immunoglobulin, complement and acute phase protein levels in depressed patients and normal controls. Journal of Affective Disorders, 30, 283–288.
Song, C, Merali, Z., & Anisman, H. (1998). Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience, in press.
Sonti, G., Ilyin, S. E., & Plata-Salaman, C. R. (1996). Anorexia induced by cytokine interactions at patho-physiological concentrations. American Journal of Physiology, 270, R1394–R1402.
Strijbos, P. J. & Rothwell, N. J. (1995). Interleukin-1 beta attenuates excitatory amino acid-induced neurode-generation in vitro: Involvement of nerve growth factor. Journal of Neuroscience, 15, 3468–3478.
Suzuki, E., Shintani, F., Kanba, S., Asai, M., & Nakaki, T. (1997). Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various brain regions. Cellular Molecular Neurobiology, 17, 557–562.
Takao, T., Tojo, C, Nishioka, T, Kurokawa, H., Takemura, T., Hashimoto, K., & De Souza, E. B. (1994). Reciprocal modulation of corticotropin-releasing factor and interleukin-1 receptors following ether-laparotomy stress in the mouse. Brain Research, 660, 170–174
Taupin, V., Toulmond, S., Serrano, A., Benavides, J., & Zavala, F. (1993). Increase in IL-6, IL-1, and TNF levels in rat brain following traumatic lesion. Journal of Neuroimmunology, 42, 177–186.
Terao, A., Oikawa, M, & Saito, M. (1993). Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Research, 622, 257–261.
Tilders, F. J. H., Schmidt, E. D., & De Goeij, D. C. E. (1993). Phenotypic plasticity of CRF neurons during stress. Annals of the New York Academy of Sciences, 697, 39–52.
van Dam, A-M., Brouns, M., Louisse, S., & Berkenbosch, F. (1992). Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Research, 588, 291–296.
Watkins, L. R., Maier, S. F., & Goehler, L. E. (1995). Cytokine-to-brain communication: A review & analysis of alternative mechanisms. Life Sciences, 11, 1011–1026.
Whishaw, I. Q. (1985). Formation of a place learning-set by the rat: a new paradigm for neurobehavioral studies. Physiology & Behavior, 35, 139–143.
Whitnall, M. H., Perlstein, R. S., Mougey, E. H., & Neta, R. (1992). Effects of interleukin-1 on the stress responsive and nonresponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology, 131, 37–44.
Wise, R. A. (1985). The anhedonia hypothesis: Mark III. Behavioural Brain Science, 8, 178–186.
Yabuuchi, K., Sharma, S., Catania, A. P., & Lipton, M. (1996). Induction of interleukin-1β mRNA in the hypothalamus following subcutaneous injections of formalin into the rat hind paws. Neuroscience Letters, 207, 109–112.
Yang, Z-J., Koseki, M., Meguid, M. M., Gleason, J. R., & Debonis, D. (1994). Synergistic effect of rhTNF-a and rhIL-la in inducing anorexia in rats. American Journal of Physiology, 36, R1056–R1064.
Yirmiya, R. (1996). Endotoxin produces a depressive-like episode in rats. Brain Research, 711, 163–174.
Zacharko, R. M. & Anisman, H. (1991). Stressor-provoked alterations of intracranial self-stimulation in the mesocorticolimbic system: An animal model of depression. In P. Willner & J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action (pp. 411–442). New York: Wiley.
Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. (1994). Cytokine-specific central monoamine alterations induced by interleukin (IL)-l, IL-2, and IL-6. Brain Research, 643, 40–9.
Zhou, D. H., Shanks, N., Riechman, S. E., Liang, R. M., Kusnecov, A. W, & Rabin, B. S. (1996). Interleukin-6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology, 63, 227–236.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Anisman, H., Merali, Z. (1999). Anhedonic and Anxiogenic Effects of Cytokine Exposure. In: Dantzer, R., Wollman, E.E., Yirmiya, R. (eds) Cytokines, Stress, and Depression. Advances in Experimental Medicine and Biology, vol 461. Springer, New York, NY. https://doi.org/10.1007/978-0-585-37970-8_12
Download citation
DOI: https://doi.org/10.1007/978-0-585-37970-8_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46135-4
Online ISBN: 978-0-585-37970-8
eBook Packages: Springer Book Archive